EXCERPT George Town, Cayman Islands, February 06, 2025 –(PR.com)– Legacy Pharma Inc. SEZC (“Legacy Pharma” or the “Company”), a specialty pharmaceutical company, announced the completion of the acquisition of InterMune, Inc. […]

EXCERPT November 2024 – Post of the acquisition from Legacy Pharma CEO, Mark Thompson “Very pleased to announce that Legacy has acquired a basket of products from Sebela Pharmaceuticals including […]

EXCERPT Tuesday, 01 October 2024 08:00 AM Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in […]

EXCERPT 04/22/2023 Press releases CHEPLAPHARM announces that it has agreed on 21st April with Eli Lilly and Company on the acquisition of the worldwide[1] commercial rights for Zyprexa®. The subject of the transaction […]

EXCERPT -Potential for up to $452 million in milestone payments with royalties in the mid-twenty percent range-Actinium receives $35 million upfront payment-Immedica obtains exclusive rights to Iomab-B in Europe, the Middle East and North Africa NEW YORK and STOCKHOLM , April […]

EXCERPT GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ — Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) is pleased to announce today a definitive license agreement with Endo Ventures Limited, […]